Medi Assist Healthcare Services (MEDIASSIST) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
11 May, 2026Executive summary
Achieved strong growth and technology-led transformation, becoming debt-free and net cash positive, enabling future investments.
AI-powered platforms processed nearly 1 million claims monthly, with industry-leading automation and fraud detection.
Expanded global partnerships and completed the acquisition and integration of Paramount Health Services and Insurance TPA Private Limited, positioning for next-generation healthcare administration.
Consolidated revenue from operations for FY26 was ₹9,047.67 million, up from ₹7,233.21 million in FY25, reflecting strong year-over-year growth.
The Board recommended a final dividend of ₹2 per equity share for FY26, subject to shareholder approval.
Financial highlights
Total income for FY26 was ₹9,232.44 million, up from ₹7,470.78 million in FY25, with operating income at ₹9,047.67 million, up 25.1% year-over-year.
Operating EBITDA was ₹945.47 million for FY26, with a margin of 19.3%.
Reported PAT for FY26 was ₹893.11 million; adjusted PAT (excluding exceptional items) was ₹688 million.
Free cash flow stood at ₹260.5 crore; net worth at ₹8,524.00 million as of March 31, 2026.
Cash and cash equivalents at year-end were ₹546.32 million, reflecting significant investing and financing activities.
Outlook and guidance
Technology and international segments expected to maintain or improve growth rates seen in FY26, with scalable AI platforms and global partnerships.
Paramount integration expected to complete by Q2FY27, enhancing operational efficiency.
Management expects continued growth in health management services, supported by recent acquisitions and expanded service offerings.
The company is monitoring regulatory changes and will adjust for any further impacts from new labour codes or ongoing legal matters.
Latest events from Medi Assist Healthcare Services
- Strong revenue growth, margin expansion, and tech adoption despite exceptional items.MEDIASSIST
Q3 25/269 Feb 2026 - Premiums, profits, and margins surged, with tech, IPO, and acquisitions fueling future growth.MEDIASSIST
Q3 24/2519 Dec 2025 - Premiums up 18.5% YoY, EBITDA margin at 22%, Paramount acquisition closed, no regulatory impact.MEDIASSIST
Q1 25/2623 Nov 2025 - FY25 delivered strong growth, major acquisitions, and robust margins with no adverse regulatory impact.MEDIASSIST
Q4 24/2520 Nov 2025 - Premiums up 20.2% YoY; profit down on acquisition costs; margin recovery targeted in 4–5 quarters.MEDIASSIST
Q2 25/2619 Nov 2025 - Premium under management and profit surged, with a successful IPO and major acquisition in progress.MEDIASSIST
Q2 24/2519 Nov 2025 - Premium under management grew 22.4% YoY, EBITDA rose 57%, and a Rs. 4 dividend was proposed.MEDIASSIST
Q1 24/2519 Nov 2025